Kieran has over 13 years' experience advising clients on IP matters relating to physics and engineering technologies. Specialist technical areas include medical devices, automotive, graphene, subsea engineering, particle accelerators, detectors, spectroscopy and microscopy.
Kieran's practice focuses mainly on the identification and procurement of IP rights and he routinely works with clients to maximise the value that may be extracted from R&D work undertaken. He has extensive experience in drafting and prosecuting patent applications and is skilled at formulating innovative strategies that strike an effective balance between protection of commercially valuable concepts and clients' budgets.
Kieran represents a wide range of clients from start ups to universities and international organisations. He is experienced in handling large global patent portfolios and works with associates across the world to provide his clients with proactive, commercially-focused advice, ensuring that the IP strategy complements his clients' objectives.
In addition to drafting and prosecution work, Kieran has experience of handling contentious matters relating to patent infringement and entitlement issues. Kieran has attended hearings before the European Patent Office's Examining Division, Opposition Division and Boards of Appeal, as well as the UK Intellectual Property Enterprise Court (IPEC), achieving positive outcomes for his clients in each forum.
Intellectual Property Law
Highest mark achieved in one of the UK professional qualifying exams
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.